The TPC2 KO side displays active cytotoxic T cells with impaired lysosome function, decreased MHC-I and PD-L1 expression, and downregulated immunity, proliferation, and metabolism, inhibiting cancer growth. The gene discussed is CD274; the disease is cancer.